期刊文献+

丙酸氟替卡松与沙丁胺醇治疗哮喘长期疗效观察 被引量:2

原文传递
导出
摘要 目的:观察丙酸氟替卡松治疗支气管哮喘中度发作的疗效及安全性。方法:选取支气管哮喘中度发作患者120例,随机分为丙酸氟替卡松治疗组和沙丁胺醇对照组,每组各60例,观察两组起效时间、达效高峰时间及疗程结束后的综合疗效。结果:在维持时间及综合疗效判断上,丙酸氟替卡松明显优于沙丁胺醇气雾剂。结论:丙酸氟替卡松对支气管哮喘的长期疗效明显优于沙丁胺醇气雾剂。
出处 《中国误诊学杂志》 CAS 2009年第12期2821-2822,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

二级参考文献19

  • 1翁俊良,郑义珊,马琼凤.小剂量布地奈德粉吸入剂治疗轻度支气管哮喘患者的远期疗效[J].中华结核和呼吸杂志,2005,28(2):88-92. 被引量:50
  • 2沈华浩,王绍斌.布地奈德干预对卵白蛋白致敏小鼠抗原激发后气道炎症及气道重塑的影响[J].中华结核和呼吸杂志,2005,28(3):154-159. 被引量:45
  • 3Ringdal W, Eliraz A, Pruzinec R, et al. The Salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med, 2003, 97(3):234-241.
  • 4Pauwels RA, Buist AS, Ma P, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: National Heart, Lung and Blood Institute and World Health Organization Golbal Initiative for Chronic Obstructive Lung Disease (GOLD): Respir Care, 2001, 46(8): 798-825.
  • 5Ind PW, Dal Negro R, Colman NC, et al. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Respir Med, 2003, 97(5): 555-562.
  • 6Hogg JC,James AL,Pare PD.Evidence for inflammation in asthma[J].Am Rev Respir Dis,1991,143(3pt2):S39-42.
  • 7WHO/NHLIB Workshop Report.Global strategy for asthma management and prevention[M].Maryland.NIH publication No.02-3659,2002.2,127-128.
  • 8Johnson M.Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease[J].Proc Am Thorac Soc,2004,1 (3):200-206.
  • 9Nelson HS,Chapman KR,Pyke SD,et al.Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaled versus separate inhalers[J].J Allergy Clin Immunol,2003,112 (1):29-36.
  • 10Barnes PJ.Molecular mechanisms of steroid action in asthma[ J ].J Allergy Clin Immunol,1996,97 (1 Pt 2):159-168.

共引文献4

同被引文献37

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部